Clinical and molecular characterization of hereditary spastic paraplegia in a spanish Southern region

References

• Fink JK. Hereditary spastic paraplegia: clinical principles and genetic advances. Semin Neurol. 2014;34(3):293–305.
   PubMed Web of Science ®Google Scholar
• Harding AE. Classification of the hereditary ataxias and paraplegias. Lancet. 1983;1(8334):1151–1155.
   PubMed Web of Science ®Google Scholar
• Finsterer J, Löscher W, Quasthoff S, et al. Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance. J Neurol Sci. 2012;318(1/2):1–18.
   PubMed Web of Science ®Google Scholar
• Salinas S, Proukakis C, Crosby A, et al. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol. 2008;7(12):1127–1138.
   PubMed Web of Science ®Google Scholar
• Ruano L, Melo C, Silva MC, et al. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology. 2014;42(3):174–183.
   PubMed Web of Science ®Google Scholar
• Lynch DS, Koutsis G, Tucci A, et al. Hereditary spastic paraplegia in Greece: characterisation of a previously unexplored population using next-generation sequencing. Eur J Hum Genet. 2016;24(6):857–863.
   PubMed Web of Science ®Google Scholar
• Stevanin G, Azzedine H, Denora P, SPATAX consortium, et al. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain. 2008;131(Pt 3):772–784. ;.
   PubMed Web of Science ®Google Scholar
• Soehn AS, Rattay TW, Beck-Wödl S, et al. Uniparental disomy of chromosome 16 unmasks recessive mutations of FA2H/SPG35 in 4 families. Neurology. 2016; 87(2):186–191.
   PubMed Web of Science ®Google Scholar
• Yoon G, Baskin B, Tarnopolsky M, et al. Autosomal recessive hereditary spastic paraplegia-clinical and genetic characteristics of a well-defined cohort. Neurogenetics. 2013;14(3/4):181–188.
   PubMed Web of Science ®Google Scholar
• Wilkinson PA, Crosby AH, Turner C, et al. A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia. Brain. 2004;127(Pt 5):973–980.
   PubMed Web of Science ®Google Scholar
• Brugman F, Scheffer H, Wokke JH, et al. Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes. Neurology. 2008; 71(19):1500–1505.
   PubMed Web of Science ®Google Scholar
• Balicza P, Grosz Z, Gonzalez MA, et al. Genetic background of the hereditary spastic paraplegia phenotypes in Hungary – an analysis of 58 probands. J Neurol Sci. 2016;364:116–121.
   PubMed Web of Science ®Google Scholar
• Tessa A, Silvestri G, de Leva MF, Modoni A, et al. A novel KIF5A/SPG10 mutation in spastic paraplegia associated with axonal neuropathy . J Neurol. 2008;255(7):1090–1092.
   PubMed Web of Science ®Google Scholar
• Stevanin G, Santorelli FM, Azzedine H, et al. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet. 2007;39(3):366–372.
   PubMed Web of Science ®Google Scholar
• Słabicki M, Theis M, Krastev DB, et al. A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia. PLoS Biol. 2010;8(6):e1000408.
   PubMed Web of Science ®Google Scholar
• Schlipf NA, Schüle R, Klimpe S, et al. AP5Z1/SPG48 frequency in autosomal recessive and sporadic spastic paraplegia. Mol Genet Genomic Med. 2014;2(5):379–382.
   PubMedGoogle Scholar
• Hourani R, El-Hajj T, Barada WH, et al. MR imaging findings in autosomal recessive hereditary spastic paraplegia. AJNR Am J Neuroradiol. 2009;30(5):936–940.
   PubMed Web of Science ®Google Scholar
• Khan TN, Klar J, Tariq M, et al. Evidence for autosomal recessive inheritance in SPG3A caused by homozygosity for a novel ATL1 missense mutation. Eur J Hum Genet. 2014;22(10):1180–1184.
   PubMed Web of Science ®Google Scholar
• Pensato V, Castellotti B, Gellera C, et al. Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48. Brain. 2014;137(Pt 7):1907–1920.
   PubMed Web of Science ®Google Scholar
• Denora PS, Schlesinger D, Casali C, et al. Screening of ARHSP-TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion. Hum Mutat. 2009;30(3):E500–19.
   PubMed Web of Science ®Google Scholar
• Casari G, Marconi R. Spastic Paraplegia 7. 2006. Aug 24 [Updated 2018 Oct 25]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1107/.
   Google Scholar
• Hirst J, Madeo M, Smets K, et al. Complicated spastic paraplegia in patients with AP5Z1 mutations (SPG48). Neurol Genet. 2016;2(5):e98.
   PubMed Web of Science ®Google Scholar
• Crimella C, Arnoldi A, Crippa F, et al. Point mutations and a large intragenic deletion in SPG11 in complicated spastic paraplegia without thin corpus callosum. J Med Genet. 2009;46(5):345–351.
   PubMed Web of Science ®Google Scholar
• Rubegni A, Storti E, Tessa A, et al. Federico Hereditary spastic paraplegia type 11 with a very late onset A, Santorelli FM. J Neurol. 2015;262(8):1987–1989.
   PubMed Web of Science ®Google Scholar
• Giannoccaro MP, Liguori R, Arnoldi A, et al. Atypical late-onset hereditary spastic paraplegia with thin corpus callosum due to novel compound heterozygous mutations in the SPG11 gene. J Neurol. 2014;261(9):1825–1827.
   PubMed Web of Science ®Google Scholar
• da Graça FF, de Rezende TJR, Vasconcellos LFR, et al. Neuroimaging in hereditary spastic paraplegias: current use and future perspectives. Front Neurol. 2018;9:1117.16
   PubMed Web of Science ®Google Scholar
• Pascual B, de Bot ST, Daniels MR, et al. “Ears of the Lynx” MRI Sign Is Associated with SPG11 and SPG15 Hereditary Spastic Paraplegia. AJNR Am J Neuroradiol. 2019;40(1):199–203.
   PubMed Web of Science ®Google Scholar
• Ylikallio E, Kim D, Isohanni P, et al. Dominant transmission of de novo KIF1A motor domain variant underlying pure spastic paraplegia. Eur J Hum Genet. 2015;23(10):1427–1430.
   PubMed Web of Science ®Google Scholar
• Citterio A, Arnoldi A, Panzeri E, et al. Variants in KIF1A gene in dominant and sporadic forms of hereditary spastic paraparesis. J Neurol. 2015;262(12):2684–2690.
   PubMed Web of Science ®Google Scholar
• https://www.omim.org/entry/601255.
   Google Scholar
• Riviere JB, Ramalingam S, Lavastre V, et al. KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. Am J Hum Genet. 2011;89(2):219–230.
   PubMed Web of Science ®Google Scholar
• Lee JR, Srour M, Kim D, et al. De novo mutations in the motor domain of KIF1A cause cognitive impairment, spastic paraparesis, axonal neuropathy, and cerebellar atrophy. Hum Mutat. 2015;36(1):69–78.
   PubMed Web of Science ®Google Scholar
• Esmaeeli Nieh S, Madou MR, Sirajuddin M, et al. De novo mutations in KIF1A cause progressive encephalopathy and brain atrophy. Ann Clin Transl Neurol. 2015;2(6):623–635.
   PubMed Web of Science ®Google Scholar
• Ohba C, Haginoya K, Osaka H, et al. De novo KIF1A mutations cause intellectual deficit, cerebellar atrophy, lower limb spasticity and visual disturbance. J Hum Genet. 2015;60(12):739–742. 8.
   PubMed Web of Science ®Google Scholar
• Yoshikawa K, Kuwahara M, Saigoh K, et al. The novel de novo mutation of KIF1A gene as the cause for Spastic paraplegia 30 in a Japanese case. eNeurologicalSci. 2019;14:34–37.
   PubMedGoogle Scholar
• Klebe S, Lossos A, Azzedine H, et al. KIF1A missense mutations in SPG30, an autosomal recessive spastic paraplegia: distinct phenotypes according to the nature of the mutations. Eur J Hum Genet. 2012;20(6):645–649.
   PubMed Web of Science ®Google Scholar
• Krenn M, Zulehner G, Hotzy C, et al. Hereditary spastic paraplegia caused by compound heterozygous mutations outside the motor domain of the KIF1A gene. Eur J Neurol. 2017;24(5):741–747.
   PubMed Web of Science ®Google Scholar
• Cheon CK, Lim SH, Kim YM, et al. Autosomal dominant transmission of complicated hereditary spastic paraplegia due to a dominant negative mutation of KIF1A, SPG30 gene. Sci Rep. 2017;7(1):12527.
   PubMed Web of Science ®Google Scholar
• Pennings M, Schouten MI, van Gaalen J, Meijer RPP, et al. KIF1A variants are a frequent cause of autosomal dominant hereditary spastic paraplegia. Eur J Hum Genet. 2020; Jan28(1):40–49.
   PubMed Web of Science ®Google Scholar
• Hotchkiss L, et al. Novel d novo mutations in KIF1A as a cause of hereditary spastic paraplegia with progressive central nervous. J Child Neurol. 2016;31(9):1114–1119.
   Google Scholar
• Fonknechten N, Mavel D, Byrne P, et al. Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet. 2000;9(4):637–644.
   PubMed Web of Science ®Google Scholar
• Parodi L, Fenu S, Barbier M, SPATAX network, et al. Spastic paraplegia due to SPAST mutations is modified by the underlying mutation and sex. Brain. 2018;141(12):3331–3342.
   PubMed Web of Science ®Google Scholar